Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative toxicological analysis of two pristine carbon nanomaterials (graphene oxide and aminated graphene oxide) and their corresponding degraded forms using human in vitro models.
de la Parra S, Fernández-Pampín N, Garroni S, Poddighe M, de la Fuente-Vivas D, Barros R, Martel-Martín S, Aparicio S, Rumbo C, Tamayo-Ramos JA. de la Parra S, et al. Toxicology. 2024 Mar 20;504:153783. doi: 10.1016/j.tox.2024.153783. Online ahead of print. Toxicology. 2024. PMID: 38518840 Free article.
High-Performance Aramids with Intrinsic Bactericide Activity.
de la Parra S, Miguel Á, Fernández-Pampín N, Rumbo C, García JM, Arnaiz A, Trigo-López M. de la Parra S, et al. ACS Appl Mater Interfaces. 2024 Feb 21;16(7):9293-9302. doi: 10.1021/acsami.3c17919. Epub 2024 Feb 7. ACS Appl Mater Interfaces. 2024. PMID: 38324477 Free PMC article.
Evidence-Based Performance Measures for Reconstruction after Skin Cancer Resection: A Multidisciplinary Performance Measure Set.
Chen A, Ray P, Rogers H, Bialowas C, Butala P, Chen M, Daveluy SD, Davidson C, Faringer P, Guarda H, Kantor J, Kaweski S, Lawrence N, Lickstein D, Lomax J, Parra S, Retson N, Suryadevara A, Smith R, Tollefson TT, Wisco OJ. Chen A, et al. Among authors: parra s. Plast Reconstr Surg. 2024 Feb 1;153(2):424e-441e. doi: 10.1097/PRS.0000000000010916. Epub 2024 Jan 24. Plast Reconstr Surg. 2024. PMID: 38266139
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial.
Shapiro AE, Sarkis E, Acloque J, Free A, Gonzalez-Rojas Y, Hussain R, Juarez E, Moya J, Parikh N, Inman D, Cebrik D, Nader A, Noormohamed N, Wang Q, Skingsley A, Austin D, Peppercorn A, Agostini ML, Parra S, Chow S, Mogalian E, Pang PS, Hong DK, Sager JE, Yeh WW, Alexander EL, Gaffney LA, Kohli A. Shapiro AE, et al. Among authors: parra s. Open Forum Infect Dis. 2023 Jul 14;10(8):ofad354. doi: 10.1093/ofid/ofad354. eCollection 2023 Aug. Open Forum Infect Dis. 2023. PMID: 37577112 Free PMC article.
Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial.
Moya J, Temech M, Parra S, Juarez E, Hernandez-Loy R, Gutierrez JCM, Diaz J, Hussain R, Segal S, Xu C, Skingsley A, Schnell G, El-Zailik A, Sager JE, Aldinger M, Alexander EL, Acloque G. Moya J, et al. Among authors: parra s. Open Forum Infect Dis. 2023 Jul 10;10(7):ofad344. doi: 10.1093/ofid/ofad344. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37520411 Free PMC article.
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Repka MX, Weise KK, Chandler DL, Wu R, Melia BM, Manny RE, Kehler LAF, Jordan CO, Raghuram A, Summers AI, Lee KA, Petersen DB, Erzurum SA, Pang Y, Lenhart PD, Ticho BH, Beck RW, Kraker RT, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group. Repka MX, et al. JAMA Ophthalmol. 2023 Aug 1;141(8):756-765. doi: 10.1001/jamaophthalmol.2023.2855. JAMA Ophthalmol. 2023. PMID: 37440213
205 results